Some private equity groups buy assets just to pull them apart and sell them in pieces, but that is the exception, not the norm. In fact, private equity has done a lot to build and improve businesses, especially small and medium-sized ones.
In this episode of The Corner Series, McGuireWoods partner Geoff Cockrell speaks
On Dec. 6, the U.S. Food and Drug Administration sent a warning letter to the owners of online hemp, tetrahydrocannabinol and cannabidiol retailer Hemp-xr.com for introducing adulterated foods into interstate commerce. FDA took issue with certain cookies, edibles, gummies and honey containing delta-8 THC and CBD because they “bear or contain an unsafe food additive.”
Notable litigation filed during November 2023 includes: (1) BB & MB WDF, LLC v. Seare, et al.; (2) Day v. Heppner, et al.; (3) Scura v. Heppner, et al.; and (4) Commodity Futures Trading Comm’n v. Young, et al.
H.I.G. Capital has agreed to acquire the spine business of ZimVie (Nasdaq: ZIMV) for $375 million, according to a news release.
H.I.G. will acquire Zimvie’s spine, motion preservation and EBI bone healing technologies.
ZimVie was formed less than two years ago when Zimmer Biomet spun out its dental and spine segments. Following the sale, ZimVie
Although investment in the orthopedic sector is not new, private equity investment interest in this specialty area continues to grow. In fact, orthopedics has become one of the leading sectors for private equity investing, just behind cardiology.
In this episode of The Corner Series, McGuireWoods partner Geoff Cockrell speaks with Scott Davis, managing
Windjammer Capital has announced it has acquired Bio X Cell (BXC).
BXC, founded in 1997 and based in Lebanon, N.H., is a producer of monoclonal antibodies for use in both in vivo and in vitro pre-clinical research applications.
Windjammer, based in Newport Beach, Calif., and Waltham, Mass., is a private equity firm focused
The U.S. Department of Health and Human Services Office of Inspector General recently issued Advisory Opinion 23-08, continuing its long-held position that the provision of value-added items and services implicates fraud and abuse laws, including the Federal Anti-Kickback Statute and the Beneficiary Inducement Civil Monetary Penalty law.
Read on to learn how manufacturers, distributors, and
Accel-KKR has announced it has invested in Ntracts.
Ntracts, founded in 2007 and based in Chattanooga, Tenn., is a provider of contract lifecycle management solutions for healthcare organizations.
Accel-KKR, based in Menlo Park, Calif., is a technology-focused investment firm. The firm pursues middle-market companies and provides a broad range of capital solutions, including
NewSpring has announced it has closed its latest fund with more than $180 million in commitments.
The fund, NewSpring Health Capital IV (NSH IV), was oversubscribed.
NSH IV made six investments prior to the final close: AeroSafe Global, BetterNight, Healthworks, Patheous Health, Prosperity Behavior Health and Verisma.
NewSpring, based in Radnor, Pa., is a
Pharos Capital Group has announced it has acquired a majority stake in RhythMedix.
RhythMedix, founded in 2013 and based in Mt. Laurel, N.J., is a manufacturer and provider of remote cardiac monitoring systems and related services.
Pharos, with offices in Dallas and Nashville, pursues control equity and mezzanine investments in lower and middle